Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Icad Inc (ICAD)

Icad Inc (ICAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,872
  • Shares Outstanding, K 26,540
  • Annual Sales, $ 17,320 K
  • Annual Income, $ -4,850 K
  • EBIT $ -6 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.47
  • Price/Sales 2.36
  • Price/Cash Flow N/A
  • Price/Book 1.39

Options Overview Details

View History
  • Implied Volatility 142.83% ( -1.55%)
  • Historical Volatility 124.77%
  • IV Percentile 39%
  • IV Rank 26.36%
  • IV High 434.25% on 02/16/24
  • IV Low 38.52% on 08/23/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 377
  • Volume Avg (30-Day) 150
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 1,747
  • Open Int (30-Day) 1,535

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4500 +19.31%
on 11/19/24
2.4200 -28.51%
on 11/13/24
-0.2300 (-11.73%)
since 10/25/24
3-Month
1.3350 +29.59%
on 10/11/24
2.4200 -28.51%
on 11/13/24
+0.1300 (+8.13%)
since 08/26/24
52-Week
1.1800 +46.61%
on 07/05/24
2.6499 -34.71%
on 03/05/24
+0.3900 (+29.10%)
since 11/24/23

Most Recent Stories

More News
iCAD, Inc. Showcases AI-Powered Breast Health Innovations and Partnership with Cascaid Health at RSNA 2024

iCAD will present AI-driven breast health solutions at RSNA 2024, showcasing new technology and partnerships to improve cancer detection.Quiver AI SummaryiCAD, Inc., a leading provider of AI-powered cancer...

ICAD : 1.7300 (+9.49%)
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

ICAD : 1.7300 (+9.49%)
Icad: Q3 Earnings Snapshot

Icad: Q3 Earnings Snapshot

ICAD : 1.7300 (+9.49%)
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

ICAD : 1.7300 (+9.49%)
iCAD's ProFound Detection Version 4.0 Gains FDA Clearance

ICAD : 1.7300 (+9.49%)
iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

ICAD : 1.7300 (+9.49%)
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024

ICAD : 1.7300 (+9.49%)
iCAD to Participate in the LD Micro Main Event XVII

Nashua, New Hampshire--(Newsfile Corp. - October 16, 2024) - iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can't hide by providing clinically...

ICAD : 1.7300 (+9.49%)
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024

ICAD : 1.7300 (+9.49%)
Icad: Q2 Earnings Snapshot

Icad: Q2 Earnings Snapshot

ICAD : 1.7300 (+9.49%)

Business Summary

Icad, Inc. designs, engineers, develops and manufactures digital image scanners, densitometers, film digitizers and related software for applications in the graphic arts, medical imaging and life sciences markets. The Company sells its products throughout the world throughvarious distributors, resellers,...

See More

Key Turning Points

3rd Resistance Point 2.2867
2nd Resistance Point 2.0833
1st Resistance Point 1.9067
Last Price 1.7300
1st Support Level 1.5267
2nd Support Level 1.3233
3rd Support Level 1.1467

See More

52-Week High 2.6499
Fibonacci 61.8% 2.0884
Fibonacci 50% 1.9149
Fibonacci 38.2% 1.7415
Last Price 1.7300
52-Week Low 1.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar